One in 10 medical products circulating in low—and center-earnings international locations (LMICs) is detestable or counterfeit, with the majority in Sub-Saharan Africa being antibacterial and antimalarial tablets. The unchecked spread of these products threatens lives and undermines smartly being care programs already battling access and quality…
Read Extra
